Abstract
Background: Dysfunction and damage of the human central nervous system can be detected with biochemical markers, and protein S-100B is the best-established such marker. The aim of this study was to evaluate whether the protein is stable during long-term storage, to establish reference values for the new Elecsys® S100 test and to compare this new method with the Liaison® Sangtec® 100 test.
Methods: We analysed blood samples from 118 blood donors and 196 patients with subarachnoid haemorrhage or head injury. The long-term stability of S-100B in frozen serum samples was evaluated with repeated analysis in 1997 and 2003 using an immunoradiometric assay. Method comparison between the Liaison® Sangtec® 100 and Elecsys® S100 tests was performed using Bland-Altman difference plots.
Results: Serum concentrations increased significantly during long-term storage (mean difference 0.15μg/L; ±2 SD, 0.55μg/L). Serum measurements using the Elecsys® S100 method in 118 healthy blood donors showed S-100B levels between 0.02 and 0.08μg/L (mean 0.05). The 95th percentile was 0.07μg/L. The Liaison® Sangtec® 100 test usually measured higher concentrations than the Elecsys® S100 method, and the difference between the two methods increased with increasing concentrations. The mean difference between the methods was 0.14μg/L (±2 SD, 0.39μg/L).
Conclusions: Protein S-100B is not stable during long-term storage and the two analytical methods are not interchangeable.
Clin Chem Lab Med 2006;44:1111–4.
References
1. Ingebrigtsen T, Romner B. Biochemical serum markers of traumatic brain injury. J Trauma 2002; 52:798–808.10.1017/CBO9780511545962.040Search in Google Scholar
2. Raabe A, Menon DK, Gupta S, Czosnyka M, Pickard JD. Jugular venous and arterial concentrations of serum S-100B protein in patients with severe head injury: a pilot study. J Neurol Neurosurg Psychiatry 1998; 65:930–2.10.1136/jnnp.65.6.930Search in Google Scholar
3. Buttner T, Weyers S, Postert T, Sprengelmeyer R, Kuhn W. S-100 protein: serum marker of focal brain damage after ischemic territorial MCA infarction. Stroke 1997; 28:1961–5.10.1161/01.STR.28.10.1961Search in Google Scholar
4. Fassbender K, Schmidt R, Schreiner A, Fatar M, Muhlhauser F, Daffertshofer M, et al. Leakage of brain-originated proteins in peripheral blood: temporal profile and diagnostic value in early ischemic stroke. J Neurol Sci 1997; 148:101–5.10.1016/S0022-510X(96)05351-8Search in Google Scholar
5. Reynolds MA, Kirchick HJ, Dahlen JR, Anderberg JM, McPherson PH, Nakamura KK, et al. Early biomarkers of stroke. Clin Chem 2003; 49:1733–9.10.1373/49.10.1733Search in Google Scholar
6. Wiesmann M, Missler U, Hagenstrom H, Gottmann D. S-100 protein plasma levels after aneurysmal subarachnoid haemorrhage. Acta Neurochir (Wien) 1997; 139:1155–60.10.1007/BF01410976Search in Google Scholar
7. Griffin WS, Yeralan O, Sheng JG, Boop FA, Mrak RE, Rovnaghi CR, et al. Overexpression of the neurotrophic cytokine S100 beta in human temporal lobe epilepsy. J Neurochem 1995; 65:228–33.10.1046/j.1471-4159.1995.65010228.xSearch in Google Scholar
8. Van Eldik LJ, Griffin WS. S100 beta expression in Alzheimer's disease: relation to neuropathology in brain regions. Biochim Biophys Acta 1994; 1223:398–403.10.1016/0167-4889(94)90101-5Search in Google Scholar
9. Romner B, Ingebrigtsen T, Kongstad P, Borgesen SE. Traumatic brain damage: serum S-100 protein measurements related to neuroradiological findings. J Neurotrauma 2000; 17:641–7.10.1089/089771500415391Search in Google Scholar PubMed
10. Ingebrigtsen T, Waterloo K, Jacobsen EA, Langbakk B, Romner B. Traumatic brain damage in minor head injury: relation of serum S-100 protein measurements to magnetic resonance imaging and neurobehavioral outcome. Neurosurgery 1999; 45:468–75.10.1097/00006123-199909000-00010Search in Google Scholar PubMed
11. Ingebrigtsen T, Romner B, Trumpy JH. Management of minor head injury: the value of early computed tomography and serum protein S-100 measurements. J Clin Neurosci 1997; 4:29–33.10.1016/S0967-5868(97)90007-2Search in Google Scholar
12. Dewitte K, Fierens C, Stöckl D, Thienpont LM. Application of the Bland-Altman plot for interpretation of method-comparison studies: a critical investigation of its practice. Clin Chem 2002; 48:799–801.10.1093/clinchem/48.5.799Search in Google Scholar
13. Raabe A, Kopetsch O, Gross U, Zimmermann M, Gebhart P. Measurements of serum S-100B protein: effects of storage time and temperature on pre-analytical stability. Clin Chem Lab Med 2003; 41:700–3.10.1515/CCLM.2003.106Search in Google Scholar PubMed
14. Djukanovic D, Hofmann U, Sucker A, Schadendorf D. Melanoma tumour markers S100B and MIA: evaluation of stability in serum and blood upon storage and processing. Br J Dermatol 2001; 145:1030–1.10.1046/j.1365-2133.2001.04545.xSearch in Google Scholar PubMed
15. Undén J, Christensson B, Bellner J, Alling C, Romner B. Serum S 100B levels in patients with cerebral and extracerebral infectious disease. Scand J Infect Dis 2004; 36:10–3.10.1080/00365540310017294Search in Google Scholar PubMed
16. Wiesmann M, Missler U, Gottmann D, Gehring S. Plasma S-100b protein concentration in healthy adults is age- and sex-independent. Clin Chem 1998; 44:1056–8.10.1093/clinchem/44.5.1056Search in Google Scholar
17. Portela LV, Tort AB, Schaf DV, Ribeiro L, Nora DB, Walz R, et al. The serum S100B concentration is age dependent. Clin Chem 2002; 48:950–2.10.1093/clinchem/48.6.950Search in Google Scholar
18. Gazzolo D, Michetti F, Bruschettini M, Marchese N, Lituania M, Mangraviti S, et al. Pediatric concentrations of S100B protein in blood: age- and sex-related changes. Clin Chem 2003; 49:967–70.10.1373/49.6.967Search in Google Scholar PubMed
19. Nygaard O, Langbakk B, Romner B. Age- and sex-related changes of S-100 protein concentrations in cerebrospinal fluid and serum in patients with no previous history of neurological disorder. Clin Chem 1997; 43:541–3.10.1093/clinchem/43.3.541Search in Google Scholar
©2006 by Walter de Gruyter Berlin New York
